C. R. Bard is no upstart in the world of medical devices. The company has been in the business for more than a century and introduced the Foley urological catheter (still one of its top sellers) in 1934. Its products fall into four general therapeutic categories: vascular, urology, oncology, and surgical specialties. Among other things, the company makes stents, catheters, and guidewires used in angioplasties and other vascular procedures; urology catheters and products used to treat urinary incontinence; and catheters for delivering chemotherapy treatments. Its line of specialty surgical tools, made by subsidiary Davol, includes devices used in laparoscopic and orthopedic procedures and for hernia repair.

Key financials for C. R. Bard, Inc. (NYSE: BCR)

Key people and executives for C. R. Bard, Inc. (NYSE: BCR)

Top competitors of C. R. Bard, Inc. (NYSE: BCR)

• Baxter International
• Boston Scientific
• Ethicon

First Research Industry Profiles Extensive Industry Intelligence

• Medical Supplies and Devices

Hoover's Industries

• Health Care
  • Health Care Products
    • Medical Devices
    • Medical Equipment & Supplies
    • Medical Products Distribution

Subsidiaries/affiliates of C. R. Bard, Inc. (NYSE: BCR)

• Bard Access Systems, Inc.
• Bard Limited
• Davol Inc.

See how C. R. Bard, Inc. (NYSE: BCR) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones

• S&P 500